4D Molecular Therapeutics, Inc. (FDMT) Form 8-K Material Events
4D Molecular Therapeutics, Inc. (FDMT) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: FDMT
CIK: 1650648
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2018 12:00:00 AM
Lead Engagement PartnerOusmane Caba
Audit LocationSan Jose, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-07 | 2026-10-05 | 4 | 0001193125-26-417068 | View SEC Doc Filr Page |
| 144 | 2026-10-05 | — | 144 Filing | 0001958244-26-000638 | View SEC Doc Filr Page |
| 8-K | 2026-09-28 | 2026-09-28 | 8-K | 0001193125-26-403424 | View SEC Doc Filr Page |
| 4 | 2026-09-22 | 2026-09-16 | 4 | 0001193125-26-398204 | View SEC Doc Filr Page |
| 4 | 2026-09-16 | 2026-09-14 | 4 | 0001193125-26-393243 | View SEC Doc Filr Page |
| 144 | 2026-09-14 | — | 144 Filing | 0001958244-26-000601 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | 4 | 0001193125-26-382245 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-19 | 4 | 0001193125-26-361096 | View SEC Doc Filr Page |
| 144 | 2026-08-19 | — | 144 Filing | 0001958244-26-000539 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | 4 | 0001193125-26-354313 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001950047-26-008269 | View SEC Doc Filr Page |
| 144 | 2026-08-13 | — | 144 Filing | 0001950047-26-008088 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001193125-26-349173 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001193125-26-349160 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-04 | 4 | 0001193125-26-335115 | View SEC Doc Filr Page |
| 144 | 2026-08-04 | — | 144 Filing | 0001958244-26-000477 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-08-03 | 4 | 0001193125-26-333014 | View SEC Doc Filr Page |
| 144 | 2026-08-03 | — | 144 Filing | 0001958244-26-000473 | View SEC Doc Filr Page |
| 8-K | 2026-07-20 | 2026-07-18 | 8-K | 0001193125-26-308409 | View SEC Doc Filr Page |
| 4 | 2026-07-14 | 2026-07-09 | 4 | 0001834021-26-000004 | View SEC Doc Filr Page |
| 144 | 2026-07-10 | — | 144 Filing | 0001958244-26-000446 | View SEC Doc Filr Page |
| 144 | 2026-07-09 | — | 144 Filing | 0001958244-26-000444 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | 4 | 0001920738-26-000004 | View SEC Doc Filr Page |
| 144 | 2026-06-30 | — | 144 Filing | 0001950047-26-006669 | View SEC Doc Filr Page |
| 8-K | 2026-06-29 | 2026-06-24 | 8-K | 0001193125-26-286880 | View SEC Doc Filr Page |